Constitutively active Cdc42 mutant confers growth disadvantage in cell transformation.

Vanni, Cristina; Ottaviano, Catherine; Guo, Fukun; Puppo, Maura; Varesio, Luigi; Zheng, Yi; Eva, Alessandra

Vanni, Cristina; Ottaviano, Catherine; Guo, Fukun; Puppo, Maura; Varesio, Luigi; Zheng, Yi; Eva, Alessandra.

Affiliation

Vanni C; Laboratorio di Biologia Molecolare, Istituto G. Gaslini, Genova, Italy.

Cell Cycle ; 4(11): 1675-82, 2005 Nov.

Article in En | MEDLINE | ID: mdl-16294011

Subject(s)

Cell Line, Transformed/cytology; Growth Inhibitors/genetics; Growth Inhibitors/metabolism; Mutation; cdc42 GTP-Binding Protein/genetics; cdc42 GTP-Binding Protein/metabolism; Animals; Cell Line, Transformed/metabolism; Growth Inhibitors/physiology; Mice; NIH 3T3 Cells; Oncogene Protein p21(ras)/physiology; cdc42 GTP-Binding Protein/physiology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cell Line, Transformed / Cdc42 GTP-Binding Protein / Growth Inhibitors / Mutation Limits: Animals Language: En Journal: Cell Cycle Year: 2005 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links